Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Bitcoin will undergo two fork events in 2026, allowing BTC holders to receive new assets at a 1:1 ratio.

Bitcoin will undergo two fork events in 2026, allowing BTC holders to receive new assets at a 1:1 ratio.

Odaily星球日报Odaily星球日报2026/07/11 19:43
Show original
According to Odaily, Bitcoin will undergo two fork events in 2026. Developer Paul Sztorc plans to launch an intentional hard fork called eCash, which is expected to activate around August 21 at block height 964,000. Another controversial soft fork proposal, BIP-110, carries a risk of causing a chain split due to unexpected issues during the August signaling window. A Bitcoin chain split will duplicate the UTXO set, granting holders a 1:1 asset balance on both ledgers. Whether the forked coins remain usable depends on replay protection, mining difficulty, and the market. Self-custody holders who control private keys at the snapshot can typically sign transactions on either chain; custodial holdings are controlled by exchanges at the snapshot, and whether users receive forked coins depends on the platform’s policy. (Bitcoin.com News)
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12